New York City, NY, Nov. 29, 2017 (GLOBE NEWSWIRE) -- A recently added report by Persistence Market Research (PMI), titled, “Global Market Study on Medical Nutrition: North America to Remain Largest Regional Market throughout the Forecast Period 2017–2025,” throws light on important aspects of the market. It offers information on the various growth drivers and restraints molding the growth path of the market, its size, and prospects going forward. It unravels the competitive dynamics in the market by leveraging popular analytical tools.
The report finds that the global parenterally administered medical nutrition market will likely rise at a 7.2% CAGR during the period between 2017 and 2025 to become worth US$6 bn by 2025 from US$3.2 bn in 2016.
Get a Sample of this Research Report: https://www.persistencemarketresearch.com/samples/16588
Primarily catalyzing growth in the medical nutrition market is the burgeoning geriatric population, which is highly susceptible to different types of age-related diseases such as diabetes, Parkinson’s disease, nervous disorders, and organ failures. Such patients suffer from restrictive food ingestion and need parenteral nutrition feeding to keep their nutritional levels intact. Increasing use of home parenteral nutrition therapy by the elderly afflicted with chronic illnesses, namely cancer, diabetes, and AIDS is providing a fillip to the global market for medical nutrition.
Apart from the substantial elderly population, another factor boosting demand in the global medical nutrition market is the increasing occurrence of chronic diseases. Chronic obstructive pulmonary disease (COPD), for instance, is a primary cause of disability and death all over the world. Most people afflicted with COPD have malnutrition and hence require nutritional support to live.
A welcome trend in the medical nutrition market is the considerable growth in investments by leading companies for developing novel parenteral nutrition drugs. Companies operating in the global medical nutrition market are trying to come up with improved nutritional products that safely fulfill the nutrition requirements of patients in different clinical conditions. In fact, numerous companies have bagged regulatory approvals for novel and efficient parenteral nutrition drugs over the past couple of years.
Request Report Methodology: https://www.persistencemarketresearch.com/methodology/16588
One factor, acting as a challenge to the medical nutrition market is the fact that parenteral administration needs proper monitoring to avoid side effects or complications. Incorrect use of this therapy ups risk of catheter infections, re-feeding syndrome, particulate contamination, and liver dysfunction. Catheter-related bloodstream infection (CRBSI) is considered to be a very serious, costly, and frequent complication caused in patients on parenteral nutrition. Further, it also leads to issues such as shortness of breath, allergic reactions, unexplained weight gain, weakness, muscle pain, and loss of appetite. These side effects and complications are negatively impacting the market.
Geographically, the global market for medical nutrition can be segmented into North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. Of them, North America currently dominates the market in terms of revenue. In the years ahead too, the region is predicted to hold on to its leading position by clocking a CAGR of 8.7% in the forecast period. The market will likely attain a value of US$2.3 bn by 2025. The main distribution channels in the medical nutrition market are retail pharmacies, hospital pharmacies, compound pharmacies, etc.
Some of the key players in the global market for medical nutrition are Allergan, Otsuka Pharmaceuticals Co., Ltd., Baxter International Inc., Danone Nutricia, Fresenius Kabi AG, Abbott Laboratories, Pfizer, Inc., Mead Johnson & Company, LLC, Sichuan Kelun Pharmaceutical Company Limited, Sanofi, and Grifols S.A.
Research Report Reference: https://www.persistencemarketresearch.com/market-research/advanced-medical-nutrition-market.asp
About Us
Persistence Market Research (PMR) is a full-service market intelligence firm specializing in syndicated research, custom research, and consulting services. PMR boasts market research expertise across the Healthcare, Chemicals and Materials, Technology and Media, Energy and Mining, Food and Beverages, Semiconductor and Electronics, Consumer Goods, and Shipping and Transportation industries. The company draws from its multi-disciplinary capabilities and high-pedigree team of analysts to share data that precisely corresponds to clients’ business needs.
PMR stands committed to bringing more accuracy and speed to clients’ business decisions. From ready-to-purchase market research reports to customized research solutions, PMR’s engagement models are highly flexible without compromising on its deep-seated research values.
Contact
Persistence Market Research
305 Broadway
7th Floor
New York City, NY 10007
United States
USA-Canada Toll Free: 800-961-0353
Email: sales@persistencemarketresearch.com
Web: https://www.persistencemarketresearch.com